ABIONYX PHARMA |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.024 EUR | +0.59% |
|
-4.66% | -20.50% |
| Mar. 14 | Abionyx Pharma: to benefit from a 1ME grant from Bpifrance | CF |
| Mar. 11 | Abionyx: reduced net loss in 2023 | CF |
Evolution of the average Target Price on ABIONYX Pharma
Price target over the last 5 years
History of analyst recommendation changes
411b.o8KbhMUnpVyS4OLqp8pvi4Vy8je-Ut3wwN3wSZ8S-SM._KSqt6xd5gb1tbuk5rIoz_c9o1rZOOydqOipPdVmwRvzis7wgETWbPOThQ~5b71551c4dcd1f294c50da641ca01971
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
1.024
EUR
Average target price
10.5
EUR
Spread / Average Target
+925.39%
High Price Target
10.5
EUR
Spread / Highest target
+925.39%
Low Price Target
10.5
EUR
Spread / Lowest Target
+925.39%
Consensus detail
Consensus revision (last 18 months)
Trading Rating
Investor Rating
ESG Refinitiv
EPS Revisions
Annual profits - Rate of surprise
- Stock Market
- Equities
- ABNX Stock
- Consensus ABIONYX Pharma
